MedTrace Logo

Osteoarthritis Topical Treatment

NCT01496326 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2011-12-21

No results posted yet for this study

Summary

This is a phase 2a clinical trial performed to evaluate the efficacy of a topical treatment of ibuprofen compared to the use of a placebo topical treatment.

A multi-center, double-blinded, randomized placebo controlled study. Study length: 14 days Dosing twice daily (b.i.d.)

Conditions

Interventions

DRUG

Ibuprofen

10% ibuprofen cream formulation at a dose of 200mg

DRUG

placebo

2 grams of placebo cream for 14 days

Sponsors & Collaborators

  • BioChemics, Inc.

    lead INDUSTRY

Principal Investigators

  • Stephen Carter, Ph.D. · BioChemics, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01496326 on ClinicalTrials.gov